ResearcherUniversity of Electronic Science and Technology of ChinaNo recent work listed

Yi Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9446-1913; OpenAlex author ID A5063055312. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper

Papers 2

Identification of key genes and pathways at the downstream of S100PBP in pancreatic cancer cells by integrated bioinformatical analysis. First author DOI 10.21037/tcr-20-2531 ↗
PLA2G16 is a mutant p53/KLF5 transcriptional target and promotes glycolysis of pancreatic cancer. Last author DOI 10.1111/jcmm.15832 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yujie Lu · 1 shared paper, 2021 · strength 0.19
- Paper Identification of key genes and pathways at the downstream of S100PBP in pancreatic cancer cells by integrated bioinfor… DOI 10.21037/tcr-20-2531 ↗
Weiming Duan · 1 shared paper, 2021 · strength 0.19
- Paper Identification of key genes and pathways at the downstream of S100PBP in pancreatic cancer cells by integrated bioinfor… DOI 10.21037/tcr-20-2531 ↗
Wei Xia · 1 shared paper, 2020 · strength 0.16
- Paper PLA2G16 is a mutant p53/KLF5 transcriptional target and promotes glycolysis of pancreatic cancer. DOI 10.1111/jcmm.15832 ↗
Ying Deng · 1 shared paper, 2020 · strength 0.16
- Paper PLA2G16 is a mutant p53/KLF5 transcriptional target and promotes glycolysis of pancreatic cancer. DOI 10.1111/jcmm.15832 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.